Vontobel Swiss Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-78,033
Closed -$4.55M 73
2020
Q4
$4.55M Buy
78,033
+16,116
+26% +$972K 2.59% 19
2020
Q3
$3.81M Buy
61,917
+808
+1% +$56K 2.66% 19
2020
Q2
$4.7M Sell
61,109
-7,110
-10% -$545K 3.09% 15
2020
Q1
$5.1M Buy
68,219
+9,742
+17% +$673K 3.88% 3
2019
Q4
$3.8M Buy
58,477
+11,774
+25% +$767K 2.48% 15
2019
Q3
$2.96M Sell
46,703
-3,676
-7% -$240K 1.91% 22
2019
Q2
$3.4M Buy
50,379
+80
+0.2% +$5.26K 1.83% 21
2019
Q1
$3.24M Sell
50,299
-2,746
-5% -$183K 3.51% 15
2018
Q4
$3.28M Buy
53,045
+48,785
+1,145% +$3.41M 2.44% 10
2018
Q3
$327K Hold
4,260
0.19% 58
2018
Q2
$302K Buy
4,260
+500
+13% +$35.3K 0.17% 64
2018
Q1
$283K Sell
3,760
-740
-16% -$58.8K 0.15% 65
2017
Q4
$321K Sell
4,500
-3,485
-44% -$265K 0.19% 60
2017
Q3
$644K Buy
7,985
+790
+11% +$60.4K 0.39% 43
2017
Q2
$509K Sell
7,195
-20,497
-74% -$1.36M 0.32% 43
2017
Q1
$1.88M Buy
27,692
+3,170
+13% +$223K 1.02% 31
2016
Q4
$1.76M Buy
24,522
+1,238
+5% +$92K 1.08% 31
2016
Q3
$1.84M Buy
23,284
+12,134
+109% +$986K 0.99% 31
2016
Q2
$837K Buy
11,150
+6,700
+151% +$595K 0.5% 44
2016
Q1
$409K Buy
+4,450
New +$401K 0.22% 49

Other funds holding GILD

Vontobel Swiss Wealth Advisors's GILD Position: Q1 2021 in Review

Vontobel Swiss Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 78,033 shares — an estimated $4.55M sold.

Vontobel Swiss Wealth Advisors first reported a position in GILD in Q1 2016 and held it in 20 quarters. The position peaked at $5.1M in Q1 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Vontobel Swiss Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Vontobel Swiss Wealth Advisors sold 78,033 Gilead Sciences shares in Q1 2021, an estimated $4.55M.
  • Vontobel Swiss Wealth Advisors first reported a position in Gilead Sciences in Q1 2016 and held it in 20 quarters.
  • Vontobel Swiss Wealth Advisors's Gilead Sciences position peaked at $5.1M in Q1 2020.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q1 2021, filed 4 May 2021.